Treatment and diagnosis of cancer
CA 2106740 A1 · Owner: Karapetian, Anait · Inventors: Karapetian, Anait
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
An isolated and biologically pure strain of oncolytic bacteria derivable from human intestinal microflora selected from Escherichia coli, Streptococcus faecalis and other intestinal bacterial species is used in a, bacterial formulation for the treatment of cancer which comprises, together, with at least one pharmaceutically acceptable diluent carrier or adjuvant, either (i) at least three such oncolytic strains of bacteria or (ii) at, least one such oncolytic strain of bacteria selected from four specified strains. In a method for the early diagnosis of cancer in a human a human, feces-derived Escherichia coli or Streptococcus faecalis sample is incubated in vitro with a standard culture …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 22, 1993. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 22, 2013.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 22, 2015.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.